ESMO 2017: Nivolumab in Combination With Radiotherapy ± Temozolomide Is Well Tolerated in Methylated and Unmethylated Newly Diagnosed Glioblastoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Only registered members have full access to PracticeUpdate content.